Skip to main content
ABINGDON HEALTH PLC logo

ABINGDON HEALTH PLC — Investor Relations & Filings

Ticker · ABDX ISIN · GB00BLF79J41 LEI · 213800XFI4WV3FBILO20 IL Manufacturing
Open in API
Filings indexed 261 across all filing types
Latest filing 2025-10-14 Share Issue/Capital Cha…
Country GB United Kingdom
Listing IL ABDX

About ABINGDON HEALTH PLC

https://www.abingdonhealth.com/

Abingdon Health PLC is a contract development and manufacturing organization (CDMO) that specializes in lateral flow assays, also known as rapid tests. The company provides a comprehensive, fully integrated service to a global customer base, supporting diagnostic projects from initial concept and development through to high-volume automated manufacturing and regulatory support. Its services cater to a wide range of sectors, including clinical, animal health, environmental, and plant health. Abingdon Health also develops and manufactures lateral flow readers and smartphone reader applications, which complement its assay services by enabling digital data capture and analysis.

Recent filings

Filing Released Lang Actions
Launch of Retail Offer
Share Issue/Capital Change Classification · 100% confidence The document is an official announcement from Abingdon Health PLC regarding the 'Launch of a Retail Offer' for new ordinary shares. It details the fundraising purpose, the offer price, the expected timetable, and eligibility criteria for shareholders. It is a regulatory announcement (RNS) concerning capital raising activities, specifically a share issue/capital change. Given the specific nature of the announcement regarding the issuance of new shares to raise capital, it fits the 'Share Issue/Capital Change' category.
2025-10-14 English
Result of Placing and Notice of GM
Share Issue/Capital Change Classification · 100% confidence The document is an official announcement from Abingdon Health PLC regarding the completion of a share placing and the notice of a General Meeting. It details the fundraising amount, the issuance of new shares, and the scheduling of a shareholder meeting to approve these actions. This falls under the category of capital and financing updates, as it describes the company's fundraising activities and the associated capital structure changes.
2025-10-14 English
Proposed Placing and Retail Offer
Capital/Financing Update Classification · 100% confidence The document is an announcement by Abingdon Health PLC regarding a proposed equity fundraising (placing and retail offer) to raise capital for business expansion and working capital. It details the purpose of the funds, the structure of the offering, and the involvement of a broker (Zeus Capital). This falls under the category of capital and financing updates.
2025-10-13 English
US CDMO Operations Update
Regulatory Filings Classification · 98% confidence The document is a regulatory news announcement (RNS) issued by Abingdon Health PLC regarding an operational update on its US CDMO facilities. It provides details on new contract wins and expansion plans. Since it is a general corporate announcement distributed via the London Stock Exchange's RNS service and does not fit into specific categories like financial reports, earnings releases, or shareholder meeting materials, it is classified as a Regulatory Filing.
2025-09-01 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is a formal notification of a share sale by a Person Discharging Managerial Responsibilities (PDMR), specifically Chris Yates, the Chief Commercial Officer of Abingdon Health plc. It includes the standard regulatory disclosure table required for such transactions, detailing the price, volume, and nature of the transaction. This aligns perfectly with the definition of a Director's Dealing (DIRS) filing.
2025-08-14 English
Trading update
Earnings Release Classification · 100% confidence The document is a 'Trading update' issued by Abingdon Health plc. It provides preliminary financial highlights (revenue expectations for FY25) and operational updates (contract wins, acquisitions, and site openings) ahead of the full annual report publication. It explicitly states that the final results are expected in October 2025. This fits the definition of an Earnings Release (ER), which covers initial announcements of periodical financial results and key highlights. FY 2025
2025-08-05 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.